MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 16:04:59 2024-05-24 EDT | ||
| 5.16 EUR | -5.49% |
|
| Current month | -20.96% | ||
| 1 month | -23.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 5.13 | -6.04% |
| 24-05-23 | 5.46 | -8.54% |
| 24-05-22 | 5.97 | +4.01% |
| 24-05-21 | 5.74 | -19.38% |
| 24-05-20 | 7.12 | -7.41% |
Real-time Borsa Italiana
Last update May 24, 2024 at 04:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1XU17 | |
| ISIN | NLBNPIT1XU17 |
| Date issued | 2023-12-18 |
| Strike | 43.4 € |
| Maturity | 2035-12-20 (4227 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.25 € |
|---|---|
| Lowest since issue | 4.53 € |
| Spread | 0.6 € |
| Spread % | 10.97% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- P1XU17 Certificat
